ReviewGut microbes2026
Revisiting gut microbiota-driven ammonia metabolism: from disease burden to physiological adaptation.
Review in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ammonia homeostasis is governed by interconnected host and microbial pathways, including hepatic ureagenesis, glutamine synthesis, and gut microbiota-mediated urea hydrolysis, proteolysis, and amino acid deamination. Ammonia has historically been viewed primarily as a nitrogenous waste product and neurotoxic molecule, a concept strongly supported by studies of hyperammonemia and hepatic encephalopathy. Impaired hepatic clearance, portosystemic shunting, and enhanced gut-derived ammonia input increase systemic ammonia burden and are linked to neurological dysfunction, muscle wasting, immune dysregulation, and progression of liver disease. In the gut lumen and mucosal environment, however, gut microbes not only generate ammonia but can also reuse ammonia-derived nitrogen for amino acid synthesis, microbial biomass formation, and community nitrogen exchange. Evidence from selected physiological and preclinical models indicates that microbiota-derived ammonia may contribute to nitrogen recycling, microbial community maintenance, enteric neural regulation, or metabolic adaptation under defined conditions. These roles are more context-specific and less broadly established than the pathological effects of systemic hyperammonemia. When epithelial barrier integrity is compromised, hepatic clearance declines, or host buffering reserves are depleted, elevated ammonia can increase epithelial exposure, portal ammonia input, or peripheral blood ammonia. Conversely, evidence that reduced microbiota-derived ammonia contributes to disease remains limited and currently comes mainly from selected animal models. This review re-examines ammonia metabolism from a gut microbiota-centered perspective. We discuss the ecological origins, spatial distribution, exposure characteristics, host-interface effects, and context-specific outcomes of microbiota-derived ammonia in physiology and disease, and discuss how ammonia should be measured, stratified, and targeted in microbial nitrogen metabolism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.